This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Sara T. K. Henry | |
|---|---|
| Name | Sara T. K. Henry |
| Birth date | 1970s |
| Birth place | Boston, Massachusetts |
| Nationality | American |
| Occupation | Biochemist; University Professor; Science Communicator |
| Alma mater | Brown University; Massachusetts Institute of Technology; Harvard Medical School |
| Known for | RNA editing; CRISPR delivery; science policy advocacy |
| Awards | MacArthur Fellowship; National Academy of Sciences membership |
Sara T. K. Henry
Sara T. K. Henry is an American biochemist, molecular biologist, and academic known for contributions to RNA editing, genome engineering, and science policy. Her work spans laboratory research at major institutions, leadership roles in interdisciplinary centers, and public engagement with organizations in Boston and Washington, D.C. Henry's career intersects experimental biology, translational medicine, and advocacy within scientific societies and funding agencies.
Born in Boston, Massachusetts, Henry grew up in a family with ties to Massachusetts General Hospital, Harvard University, and the local biotechnology community centered around Kendall Square. She completed a Bachelor of Science at Brown University where she studied under mentors affiliated with the National Institutes of Health and participated in summer research programs at Cold Spring Harbor Laboratory and the Broad Institute.
Henry earned a Ph.D. in biochemistry and molecular biology from the Massachusetts Institute of Technology with thesis work contributed to laboratories collaborating with the Howard Hughes Medical Institute and the Whitehead Institute. During graduate training she worked on RNA modification pathways alongside scientists from the Max Planck Society and presented findings at meetings hosted by the American Society for Biochemistry and Molecular Biology and the Gordon Research Conferences. Postdoctoral training was completed at Harvard Medical School in a lab partnered with investigators from the National Science Foundation and the Sloan Kettering Institute.
Henry began her independent faculty career at Stanford University then moved to a tenure-track position at Columbia University, where she established an interdisciplinary laboratory interacting with researchers from the New York Genome Center, the Rockefeller University, and the Weill Cornell Medicine community. She later returned to Massachusetts General Hospital as a principal investigator and joined the faculty of Harvard Medical School.
In institutional leadership, Henry served as director of a translational genomics center affiliated with the Broad Institute and co-founded a biotechnology incubator in Cambridge, Massachusetts that partnered with MIT and Harvard Business School. She has been an advisor to the National Institutes of Health and a member of working groups convened by the National Academies of Sciences, Engineering, and Medicine and the World Health Organization on genome-editing governance.
Henry's career includes collaborations with industry partners such as Genentech, Moderna, and CRISPR Therapeutics, and she has held visiting professorships at Oxford University and research fellowships at the Wellcome Trust. She has testified before committees of the United States Congress and contributed to policy briefings for the European Commission and the U.S. Food and Drug Administration.
Henry's laboratory focused on enzymatic mechanisms of RNA editing and delivery systems for nucleic acid therapeutics, publishing in high-impact venues alongside coauthors from the Salk Institute, the University of California, Berkeley, and the University of Cambridge. Her publications address targeted adenosine-to-inosine editing, programmable deaminases linked to delivery platforms developed with researchers from Stanford University School of Medicine, Yale School of Medicine, and the Johns Hopkins University School of Medicine.
She has authored reviews and perspectives in journals edited by entities such as the Nature Publishing Group, the Cell Press family, and the American Association for the Advancement of Science, often synthesizing findings from consortia including the ENCODE Project, the Human Genome Project legacy groups, and the 1000 Genomes Project. Henry contributed chapters to volumes published by the Cold Spring Harbor Laboratory Press and was a frequent speaker at conferences organized by the International Society for Computational Biology, the American Association of Immunologists, and the Biophysical Society.
Her translational work on CRISPR delivery vehicles involved partnerships with the Defense Advanced Research Projects Agency and the Bill & Melinda Gates Foundation and produced methodological papers widely cited by teams at UC San Francisco, Imperial College London, and the Karolinska Institutet. Coauthored clinical translational studies linked to collaborators at Massachusetts Eye and Ear, Dana-Farber Cancer Institute, and Brigham and Women's Hospital explored therapeutic applications in genetic disease and oncology.
Henry's recognition includes election to the National Academy of Sciences and receipt of a MacArthur Fellowship. She has been awarded investigator grants from the Howard Hughes Medical Institute and multiple program awards from the National Institutes of Health, including support from the National Institute of Allergy and Infectious Diseases and the National Institute of General Medical Sciences. Henry is a recipient of early-career awards from the American Society for Biochemistry and Molecular Biology and a lifetime achievement honor from the American Association for the Advancement of Science.
She has been named to lists compiled by Nature and the Science journals highlighting leading scientists, and has held endowed chairs sponsored by the Milken Institute and the Simons Foundation.
Henry resides in Cambridge, Massachusetts, and has been active in community science outreach through partnerships with the Boston Public Library, the Museum of Science, Boston, and local public schools partnered with the City of Cambridge. She has mentored trainees who proceeded to positions at institutions including Princeton University, Caltech, ETH Zurich, and the University of Tokyo.
Her legacy includes methodological advances adopted broadly by laboratories at MIT, Harvard University, Stanford University School of Medicine, and international centers such as the Pasteur Institute and the Riken Institute. Henry's influence extends into policy through contributions to statements by the National Academy of Medicine, guidance from the World Health Organization, and advisory roles with the Bill & Melinda Gates Foundation and the Wellcome Trust.
Category:American biochemists